ScholarLens Back to search
2006•Clinical & Translational OncologyRequires access

Randomized Study of Cefepime versus Ceftazidime plus Amikacin in Patients with Solid Tumors Treated with High Dose Chemotherapy (HDC) and Peripheral Blood Stem Cell Support (PBSCS) with Febrile Neutropenia

Antonio Jimeno, Alberto Arcediano, Susana Bezares, Maria Luz Amador, Lucía González‐Cortijo, Eva Ciruelos, Luis Robles, Daniel Castellano, Luis Paz‐Ares, Carlos Lumbreras, Javier Hornedo, H. Cortés-Funes

Open publisher page 5 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Cefepime, Medicine, Febrile neutropenia, Amikacin, Ceftazidime, Neutropenia, Internal medicine, Absolute neutrophil count

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Randomized Study of Cefepime versus Ceftazidime plus Amikacin in Patients with Solid Tumors Treated with High Dose Chemotherapy (HDC) and Peripheral Blood Stem Cell Support (PBSCS) with Febrile Neutropenia — Research Paper | ScholarLens